Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B

Mathur SP, Landen CP, Datta SM, Hoffmann MC, Mathur RS, Young RC. Insulin-like growth factor II levels in gynecological cancers. J. Am. Rep. Immunol. 49(2):113–9, 20. Mathur, 2000, Cervical epidermal growth factor receptor [EGF-R] and insulin-like growth factor II [IGF-II] levels in women with cervical cancer and cervical intraepithelial neoplasia [CIN], Am. J. Reprod. Immunol., 44, 222, 10.1111/j.8755-8920.2000.440406.x Mathur, 2003, Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer, Gynecol. Oncol., 91, 486, 10.1016/j.ygyno.2003.08.023 Mathur, 2005, Early diagnosis of cervical cancer: beyond human papilloma virus (HPV) testing, Dis. Markers, 21, 1 Karaviannakis, 2002, Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival and rumor surgery, Ann. Surg., 236, 37, 10.1097/00000658-200207000-00007 Holzer, 2001, Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors, Med. Pediatr. Oncol., 36, 601, 10.1002/mpo.1136 Kitamura, 1998, Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients, Oncol. Rep., 5, 1419 Van Trappen, 2002, A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer, Br. J. Cancer, 87, 537, 10.1038/sj.bjc.6600471 Bachtiary, 2002, Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival, Cancer Lett., 179, 197, 10.1016/S0304-3835(01)00872-2 Van Trappen, 2003, Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different grades of cervical carcinogenesis, J. Pathol., 201, 544, 10.1002/path.1467 Fujimoto, 2004, Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers, Br. J. Cancer, 91, 466, 10.1038/sj.bjc.6601963 Scavelli, 2004, Lymphatics at the crossroads of angiogenesis and lymphangiogenesis, J. Anat., 204, 433, 10.1111/j.0021-8782.2004.00293.x Schoppmann, 2002, Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis, Am. J. Pathol., 161, 947, 10.1016/S0002-9440(10)64255-1 Pepper, 2003, Lymphangiogenesis and tumor metastasis, Cell Tissue Res., 314, 167, 10.1007/s00441-003-0748-7 Nisato, 2003, Lymphangiogenesis and tumor metastasis, Thromb. Haemostasis, 90, 591, 10.1160/TH03-04-0206 Kimura, 2003, Vascular endothelial growth factor C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma, Oncol. Rep., 10, 1747 Liu, 2004, Expression and significance of VEGF-C and FLT-4 in gastric cancer, World J. Gastroenterol., 10, 352, 10.3748/wjg.v10.i3.352 Hung, 2003, Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors, J. Clin. Endocrinol. Metab., 88, 3694, 10.1210/jc.2003-030080 Tang, 2001, Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer, Pancreas, 22, 285, 10.1097/00006676-200104000-00010 Holland, 2003, Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer, Br. J. Cancer, 89, 891, 10.1038/sj.bjc.6601194 Arencibia, 2001, Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness, Int. J. Oncol., 19, 571 Gunningham, 2000, The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers, Clin. Cancer Res., 6, 4278 Stearns, 2004, Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF-D and flt-4t (Delta773–1081) overexpression is diagnostic for sentinel lymph node metastasis, Lab. Invest., 84, 785, 10.1038/labinvest.3700075 Tamura, 2004, Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer, Chest, 126, 342, 10.1378/chest.126.2.342 Li, 2001, Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D, Int. J. Biochem. Cell Biol., 33, 421, 10.1016/S1357-2725(01)00027-9 Shin, 2002, VEGF-C mediates cyclic pressure-induced endothelial cell proliferation, Physiol. Genomics, 11, 245, 10.1152/physiolgenomics.00068.2002 Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YN, Smith SK, Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J. Clin. Endocrinol. Metab. 86(4):1823–34. Hoar, 2003, Co-expression of vascular endothelial growth factor C [VEGF-C] and C-erbB2 in human breast carcinoma, Eur. J. Cancer, 39, 1698, 10.1016/S0959-8049(03)00382-4 Kawakami, 2003, Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer, Surgery, 133, 300, 10.1067/msy.2003.45 Arinaga, 2003, Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma, Cancer, 97, 457, 10.1002/cncr.11073 Duff, 2003, Immunodetection and molecular forms of plasma vascular endothelial growth factor-C, Int. J. Oncol., 22, 339 Mathur, 2005, Vascular endothelial growth factor (VEGF) upregulates epidermal growth factor receptor and downregulates IGF-BP3 in vitro in cervical cancer: these effects are mediated through HPV-E6 in HPV positive cervical cancers, Gynecol. Oncol., 97, 206, 10.1016/j.ygyno.2004.12.011 Mathur, 2003, In vitro down regulation of growth factors by insulin-like growth factor binding protein 3 in cervical cancer, Gynecol. Oncol., 91, 410, 10.1016/S0090-8258(03)00513-4 Galen, 1975 Lane, 2005, Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines, Am. J. Reprod. Immunol., 53, 153, 10.1111/j.1600-0897.2005.00259.x